Chronic illness amplifies dengue severity risk, early care crucial

Grace was 38 when dengue first found her. The fever came and went, uncomfortable but manageable. She recovered without incident. Then, in 2013, dengue returned. This time her body responded differently. The fever spiked and fell for nearly a week, and by the time she reached the hospital, her platelet count had collapsed into single digits. She needed blood transfusions and three days in intensive care. Now 45, living with both diabetes and hypertension, Grace carries a lesson she wishes she'd known earlier: a second dengue infection can be far more punishing than the first, and chronic illness can tip the scales toward severity.

Her experience is no longer unusual. Malaysia reported 65,979 dengue cases through epidemiological week 35 this year—a 66 percent jump from the 39,616 cases recorded during the same period in 2025. The health ministry has attributed the surge partly to dengue's cyclical nature and a shift in the dominant virus type. DENV-3 is now circulating widely across the country, and that matters because previous infection with one dengue type offers protection only against that specific strain, not all four. Someone who recovered from dengue caused by DENV-1 remains vulnerable to DENV-3, and that second encounter carries a substantially higher risk of severe disease.

Dr. Ganasan Chelladurai, a consultant emergency physician, sees the pattern clearly in his practice. The patients who deteriorate most rapidly tend to be older adults carrying obesity and diabetes. "When they come to us late, management becomes much more difficult," he said. Research backs this observation. A 2026 study of hospitalized adults in northern Vietnam found that those with chronic conditions were roughly twice as likely to develop severe dengue. Studies from Brazil documented markedly higher death rates among hospitalized dengue patients with underlying illnesses. The risk is real, though it varies by condition and individual circumstance. Diabetes, hypertension, heart disease, kidney disease, and obesity have all been associated with worse outcomes. This does not mean everyone with a chronic condition will face severe dengue, nor that healthy people are guaranteed safety. But those with underlying illness may need earlier medical evaluation and closer observation.

The danger lies partly in timing. Dengue often begins with fever, body aches, and exhaustion. But in some patients, the illness worsens precisely when the fever breaks—a counterintuitive shift that catches people off guard. Warning signs include persistent vomiting or diarrhea, severe abdominal pain, spontaneous bleeding, breathing difficulty, marked weakness, confusion, poor appetite, or sudden deterioration. Ganasan recalled a young man who arrived at the emergency department complaining of vomiting, diarrhea, and exhaustion but no fever. Only when pressed did the patient mention a fever three days prior. Blood work showed low blood pressure and a dangerously low platelet count. Testing confirmed dengue. "The fever can disappear just as complications begin," Ganasan explained. For older patients and those with chronic illness, this window can narrow quickly. Bleeding or dangerously low blood pressure may develop with little warning.

One case remains with Ganasan. A man in his early 50s, diabetic and obese, who smoked, pushed through two days of fever and body aches because he was his family's sole earner. By day four, he could barely rise from bed, could not eat or drink. But he feared hospital admission would cost him his job and the income his family depended on. He sought emergency care only after vomiting blood. Despite transfusions and intensive care, he died. His wife was left with two young children, no savings, and no clear path forward. "Doctor, I don't know how to take care of my children. I don't know how to move on," she asked him. For Ganasan, the case illustrates a truth that extends beyond medicine: dengue's consequences ripple outward, disrupting entire families, the people who care for the sick, the children who depend on them, and the plans they have made together.

Why does a second dengue infection pose greater risk? The answer lies in how the immune system responds. A previous dengue infection typically provides durable protection against that particular virus type but not the others. When someone encounters a different type years later, their immune system's prior exposure can paradoxically amplify the severity of the new infection—a phenomenon known as antibody-dependent enhancement. DENV-3 itself is not inherently more infectious or dangerous than other types. Its significance lies in population immunity. People who have never encountered DENV-3 remain susceptible. Those previously infected with a different type face elevated risk during a later infection. A shift in the dominant virus type therefore leaves more people vulnerable, while chronic illness remains a separate factor that can independently influence how severe the disease becomes.

Ganasan's approach to each patient is holistic: he considers age, underlying conditions, previous dengue history, and the speed at which symptoms are changing. Prevention remains the foundation. Removing stagnant water, covering water containers, using repellents and screens, wearing protective clothing, and participating in neighborhood clean-ups all matter. Vaccination can provide additional protection for some people, though those interested should consult a healthcare professional about whether it is appropriate for their circumstances. The message is clear and urgent: do not wait for dengue to appear serious before treating it seriously. Early assessment and close monitoring can mean the difference between recovery and catastrophe, between a family staying intact and a family fractured by loss.